Vireo Growth (VREOF) Current Leases (2020 - 2026)
Vireo Growth (VREOF) posted Current Leases of $6.1 million for Q1 2026, up 69.44% sequentially from $3.6 million in Q4 2025, and up 430.9% YoY from $1.1 million in Q1 2025.
Vireo Growth (VREOF) Current Leases (2020 - 2026) Analysis & Trends
Vireo Growth has reported Current Leases for 7 years, with the latest figure at $6.1 million in Q1 2026.
- Quarterly Current Leases rose 430.9% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (up 430.9% YoY) and the FY2025 annual result came in at $3.6 million, up 157.14% from the prior year.
- Current Leases improved to $6.1 million in Q1 2026 per VREOF's latest filing, from $3.6 million in the prior quarter.
- Over five years, Current Leases peaked at $6.1 million in Q1 2026 and troughed at $882457.0 in Q1 2024.
- A 5-year average of $2.1 million and a median of $1.4 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2026: Current Leases tumbled 49.97% in 2023, then jumped 430.9% in 2026.
- Over 5 years, Current Leases stood at $1.7 million in 2022, then tumbled by 47.03% to $890013.0 in 2023, then jumped by 57.3% to $1.4 million in 2024, then soared by 157.14% to $3.6 million in 2025, then soared by 69.44% to $6.1 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $6.1 million, $3.6 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn | 13.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 953,389.00 |
| Mar 31, 2024 | 882,457.00 |
| Dec 31, 2023 | 890,013.00 |
| Sep 30, 2023 | 907,998.00 |
| Jun 30, 2023 | 888,327.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.28 Mn |